Novel Model of Integrated Care of Older Patients With Atrial Fibrillation to Prevent Heart Failure in Rural China

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65-80
SponsorJiangsu Taizhou People's Hospital

About this trial

This cluster randomized study aims to compare village doctor-led integrated care versus usual care to improve cardiovascular health, atrial fibrillation management, self-management adherence, and heart failure prevention among older rural patients with atrial fibrillation in China.

Eligibility criteria

Qualifiers

None

Disqualifiers

A definite history of heart failure, or confirmed cardiac dysfunction or heart failure based on echocardiography and/or NT-proBNP screening. Diagnostic criteria include typical heart failure symptoms or signs with reduced left ventricular ejection fraction (HFrEF, LVEF <40%), mildly reduced left ventricular ejection fraction (HFmrEF, LVEF 40-49%), or preserved left ventricular ejection fraction with elevated NT-proBNP and structural heart disease evidence (HFpEF, LVEF ≥50%, with at least one of the following: LAVI >40 mL/m², E/e' ≥15, or TRV >2.8 m/s).

Expected survival of less than 12 months.

Severe renal insufficiency, defined as creatinine clearance <30 mL/min, or currently receiving dialysis treatment.

Cardiac dysfunction caused by reversible secondary causes, including hyperthyroid heart disease, anemic heart disease, or uncorrected congenital heart disease.

Trial design

Treatments tested in this trial

  • Village-Doctor Led Integrated Care
  • Usual Care

Treatment groups

1,356 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Jiangsu Taizhou People's Hospital

Lead sponsor

The First Affiliated Hospital with Nanjing Medical University

Collaborator